M
Mariana Oncology
Delivering innovative, safe and effective radiopharmaceutical care for solid cancers
About Mariana Oncology
Mariana Oncology is a healthcare startup focused on revolutionizing cancer treatment. The company's primary mission is to treat the most challenging solid tumors with safe, effective, and highly targeted therapies, aiming to deliver a superior standard of care. Their client base primarily consists of cancer patients, and they operate in the healthcare and pharmaceutical market.
Mariana Oncology's business model revolves around the development and provision of innovative oncology treatments. They generate revenue through the sale of these treatments to healthcare providers and patients. Additionally, they utilize personal information to enhance service delivery, always ensuring to maintain the highest level of privacy and confidentiality.
The company also creates and uses anonymous data derived from the personal information they collect. This data is used to analyze and improve their services and promote their business. They may also share this anonymous data with third parties for lawful business purposes.
Mariana Oncology operates under strict adherence to United States and foreign intellectual property laws, ensuring that their content and trademarks are protected. They also provide options for users to opt-out of certain data collection practices, ensuring user privacy and data protection.
In conclusion, Mariana Oncology is a promising startup in the healthcare sector, with a strong focus on innovative cancer treatments, data-driven service improvement, and stringent adherence to privacy and intellectual property laws.
Source: Dealroom company dataAt a glance
- Founded
- 2020
- Headquarters
- Woburn, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A9 investors entered at this stage
Atlas Venture
RA Capital Management
Access Biotechnology
Atlas Ventures
Nextech Invest
Forbion Capital Partners
Eli Lilly
Surveyor Capital
Deep Track Capital
Series B and later5 investors entered at this stage
- FPForbion Capital Partners
- DCDeep Track Capital
- SCSurveyor Capital
- ELEli Lilly
- NINextech Invest
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Patents
15 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mariana Oncology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mariana Oncology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
